These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 38140142)

  • 1. mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions.
    Okuyama R
    Vaccines (Basel); 2023 Nov; 11(12):. PubMed ID: 38140142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs.
    Farlow A; Torreele E; Gray G; Ruxrungtham K; Rees H; Prasad S; Gomez C; Sall A; Magalhães J; Olliaro P; Terblanche P
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Vaccine Platforms in Enhancing T-Cell Response.
    Ura T; Takeuchi M; Kawagoe T; Mizuki N; Okuda K; Shimada M
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors, enablers and challenges for COVID-19 vaccine development.
    Excler JL; Saville M; Privor-Dumm L; Gilbert S; Hotez PJ; Thompson D; Abdool-Karim S; Kim JH
    BMJ Glob Health; 2023 Jun; 8(6):. PubMed ID: 37277195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pandemic-response adenoviral vector and RNA vaccine manufacturing.
    Kis Z; Tak K; Ibrahim D; Papathanasiou MM; Chachuat B; Shah N; Kontoravdi C
    NPJ Vaccines; 2022 Mar; 7(1):29. PubMed ID: 35236838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus disease 2019 (COVID-19) vaccine platforms: how novel platforms can prepare us for future pandemics: a narrative review.
    Lee JK; Shin OS
    J Yeungnam Med Sci; 2022 Apr; 39(2):89-97. PubMed ID: 35152616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Traditional Vaccine Development Strategies to SARS-CoV-2.
    Rando HM; Lordan R; Lee AJ; Naik A; Wellhausen N; Sell E; Kolla L; ; Gitter A; Greene CS
    mSystems; 2023 Apr; 8(2):e0092722. PubMed ID: 36861991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Race for a COVID-19 Vaccine: Current Trials, Novel Technologies, and Future Directions.
    Brown S; Brown T; Cederna PS; Rohrich RJ
    Plast Reconstr Surg Glob Open; 2020 Oct; 8(10):e3206. PubMed ID: 33173705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral vector-based platforms for developing effective vaccines to combat respiratory viral infections.
    Elkashif A; Alhashimi M; Sayedahmed EE; Sambhara S; Mittal SK
    Clin Transl Immunology; 2021; 10(10):e1345. PubMed ID: 34667600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic.
    Mendonça SA; Lorincz R; Boucher P; Curiel DT
    NPJ Vaccines; 2021 Aug; 6(1):97. PubMed ID: 34354082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status.
    Chavda VP; Bezbaruah R; Valu D; Patel B; Kumar A; Prasad S; Kakoti BB; Kaushik A; Jesawadawala M
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccines and the pandemic: lessons learnt for other neglected diseases and future threats.
    Hotez PJ; Gilbert S; Saville M; Privor-Dumm L; Abdool-Karim S; Thompson D; Excler JL; Kim JH
    BMJ Glob Health; 2023 Jun; 8(6):. PubMed ID: 37277196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines.
    Sayedahmed EE; Elkashif A; Alhashimi M; Sambhara S; Mittal SK
    Vaccines (Basel); 2020 Oct; 8(4):. PubMed ID: 33019589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral vector and nucleic acid vaccines against COVID-19: A narrative review.
    Khoshnood S; Ghanavati R; Shirani M; Ghahramanpour H; Sholeh M; Shariati A; Sadeghifard N; Heidary M
    Front Microbiol; 2022; 13():984536. PubMed ID: 36118203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa.
    Kana BD; Arbuthnot P; Botwe BK; Choonara YE; Hassan F; Louzir H; Matsoso P; Moore PL; Muhairwe A; Naidoo K; Ndomondo-Sigonda M; Madhi SA
    Lancet Infect Dis; 2023 Aug; 23(8):e288-e300. PubMed ID: 37290473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reported COVID-19 vaccines side effects among Algerian athletes: a comparison between inactivated virus, adenoviral vector, and mRNA COVID-19 vaccines.
    Oudjedi A; Allali A; Bekli A; Lounis M; Ben Saad H; Boukoufa M
    Phys Sportsmed; 2024 Apr; 52(2):134-146. PubMed ID: 36876437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. US public investment in development of mRNA covid-19 vaccines: retrospective cohort study.
    Lalani HS; Nagar S; Sarpatwari A; Barenie RE; Avorn J; Rome BN; Kesselheim AS
    BMJ; 2023 Mar; 380():e073747. PubMed ID: 36858453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
    Kumar Suri R; Hayman B; Prasad SD; Makhoana M; Tippoo P
    Vaccine; 2022 Jun; 40(26):3495-3505. PubMed ID: 35577632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurturing Deep Tech to Solve Social Problems: Learning from COVID-19 mRNA Vaccine Development.
    Okuyama R
    Pathogens; 2022 Dec; 11(12):. PubMed ID: 36558803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.
    Grasselli G; Zanella A; Carlesso E; Florio G; Canakoglu A; Bellani G; Bottino N; Cabrini L; Castelli GP; Catena E; Cecconi M; Cereda D; Chiumello D; Forastieri A; Foti G; Gemma M; Giudici R; Grazioli L; Lombardo A; Lorini FL; Madotto F; Mantovani A; Mistraletti G; Mojoli F; Mongodi S; Monti G; Muttini S; Piva S; Protti A; Rasulo F; Scandroglio AM; Severgnini P; Storti E; Fumagalli R; Pesenti A;
    JAMA Netw Open; 2022 Oct; 5(10):e2238871. PubMed ID: 36301541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.